|
|
Changes and clinical significance of serum EMPs and hs-CRP in patients with acute myocardial infarction |
YUAN Xiaohong1 LI Peng2 LIU Junhui2 |
1.Department of Inspection, the Second Affiliated Hospital of Xi′an Jiaotong University, Shaanxi Province, Xi′an 710004, China;
2.Department of Inspection, the First Affiliated Hospital of Xi′an Jiaotong University, Shaanxi Province, Xi′an 710061, China |
|
|
Abstract Objective To investigate the changes of serum endothelial-derived microparticles (EMPs) and hypersensitive C-reactive protein (hs-CRP) levels in patients with acute myocardial infarction (AMI) and its clinical significance. Methods A total of 146 patients with AMI hospitalized in the Second Affiliated Hospital of Xi′an Jiaotong University (“our hospital” for short) from January 2016 to January 2018 were selected as the observation group. Another 50 non-AMI patients with ventricular premature contractions who were treated in our hospital in the same period were selected as the control group. The levels of serum EMPs and hs-CRP were detected and compared between the two groups. Gensini score was used to evaluate the degree of vascular stenosis in the observation group, and coronary angiography was used to detect the number of vascular lesions in the observation group. The serum levels of EMPs and hs-CRP in patients with different Gensini score and vessel lesion branches were compared. The correlation between serum level of EMPs and hs-CRP and Gensini score and coronary artery lesion branches were analyzed. Results The levels of serum EMPs and hs-CRP in the observation group were higher than those in the control group, the differences were statistically significant (P < 0.05). The levels of serum EMPs and hs-CRP in the observation group increased gradually with the increase of Gensini score, the differences were statistically significant (P < 0.05). The levels of serum EMPs and hs-CRP in the observation group increased gradually with the increase of the number of vascular lesion branches, the differences were statistically significant (P < 0.05). The levels of serum EMPs and hs-CRP were positively correlated with Gensini score and the number of coronary artery lesions (EMPs: r = 0.583, 0.527; P < 0.05, hs-CRP: r = 0.634, 0.582, P < 0.05). Conclusion The levels of serum EMPs and hs-CRP in patients with AMI are abnormally elevated, and their level are closely related to the severity and extent of coronary artery involvement. EMPs, hs-CRP may be used as markers for judging the severity of AMI.
|
|
|
|
|
[1] 王静.急性心肌梗死急救护理流程优化路径应用实践分析[J].实用临床医药杂志,2016,20(10):1-3.
[2] 陈飞,喻金彦,印媛君.急性心肌梗死的流行病学及危险因素研究进展[J].浙江临床医学,2016,18(10):1954-1956.
[3] 杨增强,蔡兰兰.丹参酮ⅡA磺酸钠注射液对急性心肌梗死患者心肌酶学及心脏泵血功能的影响[J].国际中医中药杂志,2017,39(7):587.
[4] Muller G,Flecher E,Lebreton G,et al. The ENCOURAGE mortality risk score and analysis of long-term outcomes after VA-ECMO for acute myocardial infarction with cardiogenic shock [J]. Intensive Care Med,2016,42(3):370-378.
[5] Niccoli G,Scalone G,Lerman A,et al. Coronary microvascular obstruction in acute myocardial infarction [J]. Eur Heart J,2016,37(13):1024-1033.
[6] 王奇胜,王少波,段运祥.尼可地尔联合曲美他嗪对AMI患者急诊PCI术后血清hs-CRP、ESM-1、EMPs的影响[J].河北医学,2018,24(7):1072-1077.
[7] 董莹,王增武,王馨,等.中国中年人群超敏C反应蛋白与心血管事件、总死亡事件的关联研究[J].中华流行病学杂志,2018,39(4):428-432.
[8] Westman PC,Lipinski MJ,Luger D,et al. Inflammation as a Driver of Adverse Left Ventricular Remodeling After Acute Myocardial Infarction [J]. J Am Coll Cardiol,2016, 67(17):2050-2060.
[9] 许钢,李玉军,梁斌.降钙素原及高敏C反应蛋白水平与急性心肌梗死患者炎症反应及冠状动脉病变相关性研究[J].中国药物与临床,2017,17(6):848-850.
[10] 中华医学会心血管病学分会.急性心肌梗死诊断和治疗指南[J].中华心血管病杂志,2001,29(12):710-725.
[11] 丁伟,王邦宁.非高密度脂蛋白胆固醇水平与冠心病患者冠状动脉病变Gensini评分的相关性研究[J].安徽医学,2016,37(2):167-170.
[12] 缪应新,甘洁民,陈洁,等.血清神经肽Y水平与冠心病患者冠状动脉病变支数的关系[J].检验医学,2017, 32(11):1039-1042.
[13] O′Donoghue ML,Glaser R,Cavender MA,el al. Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction:A Randomized Clinical Trial [J]. JAMA,2016,315(15):1591-1599.
[14] 李璐璐,李银花,刘梅颜.中西医结合治疗急性心肌梗死的研究进展[J].中国循证心血管医学杂志,2016,8(1):115-117.
[15] Zhang Y,Cheng J,Chen F,et al. Circulating endothelial microparticles and miR-92a in acute myocardial infarction [J]. Biosci Rep,2017,37(2):BSR20170047.
[16] 薛国华,马惠芳,张守彦.非ST段抬高型急性冠脉综合征患者血清Hcy、hs-CRP与冠状动脉斑块易损性的关系[J].实用医学杂志,2016,32(19):3241-3244.
[17] Rostami R,Najafi M,Sarami R,et al. Gensini scores and well-being states among patients with coronary artery disease: A comparison study [J]. ARYA Atheroscler,2017, 13(5):205-210.
[18] 汪洋,李彩荣,王宁夫.平均血小板容积和Gensini积分对急性ST段抬高型心肌梗死患者PCI术后预后的影响[J].临床和实验医学杂志,2018,17(6):602-604.
[19] 李强,郭壮波,伍光颖,等.阿托伐他汀对急性心肌梗死大鼠内皮微颗粒及心肌细胞凋亡的影响[J].中国病理生理杂志,2015,31(2):359-363,373.
[20] 刘学武,张遐智,张芳兰.急性心肌梗死患者介入治疗后口服通心络胶囊对血清内皮细胞微粒及基质金属蛋白酶9水平的影响[J].中国药物警戒,2017,14(3):142-144,149.
[21] 韦小荣,黄丽秀,刘晓艳.高敏肌钙蛋白T和肌红蛋白联合检测在急性心肌梗死早期诊断中的应用及其临床价值[J].中国现代医生,2018,56(20):135-137.
[22] 郭春霞,付丽坤,李默,等.IGF-1、hs-CRP、NT-proBNP与老年2型糖尿病患者左心室肥厚的临床关系[J].中国医药导报,2018,15(11):120-122,142.
[23] 余家玉,赵文婷,鲍荣琦,等.高血压患者血清内皮细胞微颗粒和hs-CRP的水平检测及临床意义[J].中华全科医学,2015,13(10):1625-1626,1732.
[24] 薛有平,雷毅,刘峰,等.Hcy、IMA、MPO、hs-CRP与脑血管病患者病变程度的相关性分析[J].临床和实验医学杂志,2018,17(4):376-379.
[25] 徐菡,邸平,王珊珊,等.白介素-8、超敏C-反应蛋白及血管性假血友病因子联合检测在冠心病患者中的应用[J].中国医学装备,2017,14(9):78-81.
[26] 周静,张春艳,马维东,等.急性心肌梗死患者内皮炎症与无复流及冠脉病变严重程度的相关性[J].西安交通大学学报:医学版,2016,37(3):331-335. |
|
|
|